Daily Cardiology
Daily Cardiology Academy
Publishing Details
Contact & Outreach
About This Podcast
to enjoy learning and progressing in cardiometabolic practice
Explore Statistics
Recent Episodes
ESC 2025: β-blockers after myocardial infarction with mildly reduced ejection fraction
📚 ESC 2025 Coverage: Expanding the Benefit Zone: Can β Blockers Help Post-MI Patients with Mildly Reduced Ejection Fraction? by Dr. Yahyavi, Cardiovascular Researcher.
ESC 2025: SMuRF-less but inflamed
📚 ESC 2025 Coverage: The SMuRF-less Illusion: Inflammation Unmasks Hidden Cardiovascular Risk in Healthy Women, by Dr. Hafezi, Cardiovascular Specialist.
ESC 2025: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
📚 ESC 2025 Coverage: A Classic Revived: Digitoxin Lowers Risk in HFrEF When Added to Modern Therapy, by Dr. Talasaz, Clinical Pharmacist.
ESC 2025: Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
ESC 2025: Immediate versus staged complete revascularisation during index admission in patients
📚 ESC 2025 Coverage: All at Once or One Step at a Time? Immediate Revascularisation Falls Short of Non-Inferiority in STEMI Patients, by Dr. Soltani Moghadam, Cardiovascular Researcher.
ESC 2025: Remote Screening for Asymptomatic Atrial Fibrillation
📚 ESC 2025 Coverage: Finding the Silent Beat: Remote ECG Screening Slightly Boosts Atrial Fibrillation Detection, by Dr. Tahmtan, Fellowship of Electrophysiology.
ESC 2025: Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery
📚 ESC 2025 Coverage: Cholesterol Crushed, But Grafts Still Failed: Evolocumab Misses the Mark in NEWTON-CABG, by Dr. Ghavidel, Cardiovascular Surgeon.
ESC 2025: Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for Acute Coronary Syndrome
📚 ESC 2025 Coverage: More Isn’t Always Better: Dual Antiplatelet Therapy Falls Short After CABG for ACS, by Dr. Mehrpouya, Interventional Cardiologist.
ESC 2025: Vericiguat for patients with heart failure and reduced ejection fraction across the risk s
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrumVICTORIA and VICTOR Clinical Trials📚 ESC 2025 Coverage: Bridging Stability and Severity: Vericiguat’s…
ESC 2025: Reduction of Antihypertensive Treatment in Nursing Home Residents
Reduction of Antihypertensive Treatment in Nursing Home Residents📚 ESC 2025 Coverage: Taking the Pressure Off, Gently: Can Fewer BP Pills Help Frail Elders Thrive? by Dr. Mansouri, Internal Medicine…
ESC 2025: High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults📚 ESC 2025 Coverage: Double the Dose, Double the Defense? by Dr. Soleimani, Cardiovascular Specialist.
ESC 2025: B. Aminian, MD
Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction (TARGET-FIRST)
Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO)
Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO)
Impact 52: FINEARTS-HF: Modes of Death in HFmrEF & HFpEF
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF RCT📚 Impact 52: Finerenone and mode of death in HF: Where do we stand? A review by Dr.…
Impact 51: Thrombolysis after recent DOAC intake
📚 Impact 51: Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants (DOACs), A review by Dr. Haeri, Neurologist.
H&H Academy in 7 minutes, Episode 7
💊 Hypertension and Hyperlipidemia at your fingertips!5️⃣ H&H Academy in 7 minutes, episode 7.
Impact 50: Thrombolysis before thrombectomy: A bridge not fallen
📚 Impact 50: Thrombolysis before thrombectomy: A bridge not fallen, A review by Dr. Benam, Cardiovascular Specialist.
Case Discussion 125: DVT Prophylaxis in Post-Ischemic Stroke Patients
🫀Case Discussion 125: DVT Prophylaxis in Post-Ischemic Stroke Patients, by Dr. Bikdeli, Cardiovascular specialist.
Impact 49: SGLT2 inhibitors in CKD: are they really effective in all patients?
SGLT2 inhibitors in CKD: are they really effective in all patients?
Impact 48: DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR
DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR
Frequently Asked Questions
Daily Cardiology has published 732 episodes since January 2022, covering topics in Health & Fitness, Medicine.
Daily Cardiology is currently dormant with new episodes hourly. Average episode length is 11m.
Sign up on Grep.FM to access contact details for Daily Cardiology, including email and social media links.
